Guangbi Yao

1.2k total citations · 1 hit paper
16 papers, 972 citations indexed

About

Guangbi Yao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Guangbi Yao has authored 16 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 15 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Guangbi Yao's work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (13 papers) and Liver Disease Diagnosis and Treatment (8 papers). Guangbi Yao is often cited by papers focused on Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (13 papers) and Liver Disease Diagnosis and Treatment (8 papers). Guangbi Yao collaborates with scholars based in China, United States and Belgium. Guangbi Yao's co-authors include Nancy Little, Mary Castiglia, E. Jenny Heathcote, Anna S. Lok, Jules L. Dienstag, Stephen D. Gardner, Nancy Leung, Ching‐Lung Lai, Eugene R. Schiff and Masashi Mizokami and has published in prestigious journals such as Gastroenterology, Journal of Antimicrobial Chemotherapy and Journal of Medical Virology.

In The Last Decade

Guangbi Yao

16 papers receiving 944 citations

Hit Papers

Long-term safety of lamivudine treatment in patients with... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term safety of lamivudine treatment in patients with chronic hepatitis B
    2003 596 citations Anna S. Lok, Ching‐Lung Lai et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangbi Yao China 10 941 912 125 17 14 16 972
Watcharasak Chotiyaputta Thailand 13 555 0.6× 546 0.6× 106 0.8× 22 1.3× 15 1.1× 30 623
S. Locarnini Australia 10 487 0.5× 444 0.5× 162 1.3× 25 1.5× 15 1.1× 29 511
Jia Ma China 3 1.1k 1.1× 1.0k 1.1× 177 1.4× 16 0.9× 17 1.2× 6 1.1k
Simon Siu‐Man Sum Hong Kong 13 584 0.6× 534 0.6× 65 0.5× 43 2.5× 14 1.0× 22 647
Carolyn Campbell United States 9 498 0.5× 448 0.5× 59 0.5× 15 0.9× 24 1.7× 11 532
J. Petersen Germany 9 414 0.4× 396 0.4× 51 0.4× 21 1.2× 18 1.3× 33 470
May‐Ling Wong Hong Kong 10 623 0.7× 568 0.6× 77 0.6× 19 1.1× 7 0.5× 17 661
Shigeru Yotsumoto Japan 8 382 0.4× 372 0.4× 60 0.5× 11 0.6× 13 0.9× 11 415
Russell Fleischer United States 7 693 0.7× 678 0.7× 157 1.3× 32 1.9× 24 1.7× 7 779
Mobin Khan Bangladesh 11 548 0.6× 569 0.6× 64 0.5× 10 0.6× 6 0.4× 35 629

Countries citing papers authored by Guangbi Yao

Since Specialization
Citations

This map shows the geographic impact of Guangbi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbi Yao more than expected).

Fields of papers citing papers by Guangbi Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangbi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbi Yao. The network helps show where Guangbi Yao may publish in the future.

Co-authorship network of co-authors of Guangbi Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Guangbi Yao. A scholar is included among the top collaborators of Guangbi Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangbi Yao. Guangbi Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yao, Guangbi, et al.. (2009). [The clinical characteristics of primary biliary cirrhosis in China: a systematic review].. PubMed. 17(11). 861–6. 5 indexed citations
2.
3.
Yao, Guangbi, Chengwei Chen, Hong Ren, et al.. (2008). Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China. Hepatology International. 2(1). 136–136. 39 indexed citations
4.
Yao, Guangbi, Xia-qiu Zhou, Bao-en Wang, et al.. (2007). Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China. Hepatology International. 1(3). 373–381. 9 indexed citations
5.
Yao, Guangbi. (2007). Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China. Journal of Antimicrobial Chemotherapy. 60(2). 201–205. 28 indexed citations
6.
Yao, Guangbi, Chengwei Chen, Hong Ren, et al.. (2007). Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China. Hepatology International. 1(3). 365–372. 37 indexed citations
7.
Lesmana, Laurentius A., et al.. (2006). Hepatitis B: overview of the burden of disease in the Asia‐Pacific region. Liver International. 26(S2). 3–10. 55 indexed citations
8.
Yao, Guangbi. (2006). [Standardize the prevention and management practice of hepatitis B: comment on the Chinese 2005 guideline for hepatitis B infection].. PubMed. 45(11). 885–6. 1 indexed citations
9.
Lok, Anna S., Ching‐Lung Lai, Nancy Leung, et al.. (2003). Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology. 125(6). 1714–1722. 596 indexed citations breakdown →
10.
Jin, Ronghua, Zhen-Wei Lang, & Guangbi Yao. (2003). Improvement of liver histology after one year of Lamivudine therapy in patients with chronic hepatitis B. Gastroenterology. 124(4). A762–A762. 1 indexed citations
11.
Yao, Guangbi, et al.. (2002). An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.. PubMed. 115(12). 1814–8. 4 indexed citations
12.
Yao, Guangbi, et al.. (2002). [Treatment of chronic hepatitis C by bicyclum, a randomized double-blind placebo controlled trial].. PubMed. 82(14). 958–60. 4 indexed citations
13.
Ding, Xin, Masashi Mizokami, Guangbi Yao, et al.. (2001). Hepatitis B Virus Genotype Distribution among Chronic Hepatitis B Virus Carriers in Shanghai, China. Intervirology. 44(1). 43–47. 150 indexed citations
14.
Yao, Guangbi, et al.. (2000). A multicenter, randomized, controlled trial of interferon alfacon‐1 compared with α‐2a‐interferon in Chinese patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 15(10). 1165–1170. 11 indexed citations
15.
Yao, Guangbi. (2000). Treatment of chronic hepatitis B in China. Journal of Gastroenterology and Hepatology. 15(s2). E61–6. 10 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Watcharasak Chotiyaputta Breakdown of academic impact, for papers by S. Locarnini Breakdown of academic impact, for papers by Jia Ma Breakdown of academic impact, for papers by Simon Siu‐Man Sum Breakdown of academic impact, for papers by Carolyn Campbell Breakdown of academic impact, for papers by J. Petersen Breakdown of academic impact, for papers by May‐Ling Wong Breakdown of academic impact, for papers by Shigeru Yotsumoto Breakdown of academic impact, for papers by Russell Fleischer Breakdown of academic impact, for papers by Mobin Khan
Rankless by CCL
2026